FDA's hormone therapy warning rollback sparks estrogen patch shortage

FDA's hormone therapy warning rollback sparks estrogen patch shortage

The FDA's decision to rollback 'black box warnings' on hormone replacement therapy (HRT) in November 2025 has created an estrogen patch shortage. Dr. Janette Nesheiwat explains HRT's crucial benefits for millions of menopausal women and concerns about access to vital medication for hot flashes and bone loss.